METZNER; Hubert

Patent Applications and Registrations

Patent applications and USPTO patent grants for METZNER; Hubert.The latest application filed is for "method for improving the stability of purified factor viii after reconstitution".

Company Profile

11.24.40

METZNER; Hubert - Marburg DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For Improving The Stability Of Purified Factor Viii After Reconstitution App 20210308229 - HORN; Carsten ; et al.	2021-10-07
Method for improving the stability of purified Factor VIII after reconstitution Grant 10,881,717 - Horn , et al. January 5, 2	2021-01-05
Pharmaceutical Formulations Of C1 Esterase Inhibitor App 20200390845 - METZNER; Hubert ; et al.	2020-12-17
Protein Purification And Virus Inactivation With Alkyl Glycosides App 20200317727 - BRANDT; Tobias ; et al.	2020-10-08
Method For Improving The Stability Of Purified Factor Viii After Reconstitution App 20200268854 - HORN; Carsten ; et al.	2020-08-27
Truncated von Willebrand factor polypeptides for treating hemophilia Grant 10,688,157 - Schulte , et al.	2020-06-23
Proteolytically Cleavable Fusion Proteins With High Molar Specific Activity App 20200095567 - METZNER; Hubert ; et al.	2020-03-26
Method for improving the stability of purified factor VIII after reconstitution Grant 10,537,616 - Horn , et al. Ja	2020-01-21
Truncated Von Willebrand Factor Polypeptides For Treating Hemophilia App 20190263890 - SCHULTE; Stefan ; et al.	2019-08-29
Pharmaceutical Formulations Of C1 Esterase Inhibitor App 20190175683 - Metzner; Hubert ; et al.	2019-06-13
Factor VIII formulation Grant 10,238,718 - Liebing , et al.	2019-03-26
Method For Improving The Stability Of Purified Factor Viii After Reconstitution App 20190038722 - HORN; Carsten ; et al.	2019-02-07
Truncated Von Willebrand Factor Polypeptides For Treating Hemophilia App 20180161402 - SCHULTE; Stefan ; et al.	2018-06-14
Proteolytically Cleavable Fusion Proteins With High Molar Specific Activity App 20180119128 - METZNER; Hubert ; et al.	2018-05-03
Method for improving the stability of purified factor VIII after reconstitution Grant 9,956,269 - Horn , et al. May 1, 2	2018-05-01
Covalent Complex Of Von Willebrand Factor And Factor Viii, Compositions, And Uses Relating Thereto App 20180092966 - Metzner; Hubert ; et al.	2018-04-05
Pharmaceutical Formulations Of C1 Esterase Inhibitor App 20180036394 - SCHAEFER; Wolfram ; et al.	2018-02-08
Covalent complex of von Willebrand Factor and factor VIII, compositions, and uses relating thereto Grant 9,878,017 - Metzner , et al. January 30, 2	2018-01-30
Factor Viii Formulation App 20170252412 - LIEBING; Uwe ; et al.	2017-09-07
Improved Factor Viii Preparations Suitable For Therapeutic Use And Processes To Obtain These App 20170209546 - SCHMIDBAUER; Stefan ; et al.	2017-07-27
Method For Improving The Stability Of Purified Factor Viii After Reconstitution App 20160367641 - HORN; Carsten ; et al.	2016-12-22
Combined use of a sulfated glycosaminoglycan and a hyaluronidase for improving the bioavailability of factor VIII Grant 9,511,123 - Zollner , et al. December 6, 2	2016-12-06
Method for improving the stability of purified factor VIII after reconstitution Grant 9,394,353 - Horn , et al. July 19, 2	2016-07-19
Use of sulfated glycosaminoglycans for improving the bioavailability of factor VIII Grant 9,393,289 - Metzner , et al. July 19, 2	2016-07-19
Complex App 20160200794 - METZNER; Hubert ; et al.	2016-07-14
Factor VIII, von Willebrand factor or complexes thereof with prolonged in vivo half-life Grant 9,290,561 - Weimer , et al. March 22, 2	2016-03-22
Proteolytically Cleavable Fusion Proteins With High Molar Specific Activity App 20160010074 - Metzner; Hubert ; et al.	2016-01-14
Combined Use of a Sulfated Glycosaminoglycan and a Hyaluronidase for Improving the Bioavailability of Factor VIII App 20150023946 - Zollner; Sabine ; et al.	2015-01-22
Use Of Sulfated Glycosaminoglycans For Improving The Bioavailability Of Factor Viii App 20140315815 - Metzner; Hubert ; et al.	2014-10-23
Modified Coagulation Factors With Prolonged In Vivo Half-life App 20140273096 - SCHULTE; Stefan ; et al.	2014-09-18
Method for Improving the Stability of Purified Factor VIII After Reconstitution App 20140249086 - Horn; Carsten ; et al.	2014-09-04
Therapeutic Polypeptides With Increased In Vivo Recovery App 20140248686 - Weimer; Thomas ; et al.	2014-09-04
Modified coagulation factors with prolonged in vivo half-life Grant 8,754,194 - Schulte , et al. June 17, 2	2014-06-17
Factor Viii, Von Willebrand Factor Or Complexes Thereof With Prolonged In Vivo Half-life App 20140072561 - Weimer; Thomas ; et al.	2014-03-13
Therapeutic Polypeptides With Increased In Vivo Recovery App 20130337532 - Weimer; Thomas ; et al.	2013-12-19
Factor VIII, von willebrand factor or complexes thereof with prolonged in vivo half-life Grant 8,575,104 - Weimer , et al. November 5, 2	2013-11-05
Thrombin preparations and process for their production Grant 8,012,728 - Metzner , et al. September 6, 2	2011-09-06
Proteolytically Cleavable Fusion Proteins With High Molar Specific Activity App 20110189182 - METZNER; Hubert ; et al.	2011-08-04
Factor Viii, Von Willebrand Factor Or Complexes Thereof With Prolonged In Vivo Half-life App 20110183907 - Weimer; Thomas ; et al.	2011-07-28
Proteolytically cleavable fusion proteins with high molar specific activity Grant 7,939,632 - Metzner , et al. May 10, 2	2011-05-10
Method for differentiating between factor XIII deficiency states and fibrinogen deficiency states by means of thrombelastographic techniques Grant 7,939,288 - Wrabetz , et al. May 10, 2	2011-05-10
Method of Increasing the In Vivo Recovery of Therapeutic Polypeptides App 20100222554 - Weimer; Thomas ; et al.	2010-09-02
Modified Coagulation Factors With Prolonged In Vivo Half-life App 20100120664 - Schulte; Stefan ; et al.	2010-05-13
Fibrinogen purification Grant 7,550,567 - Metzner , et al. June 23, 2	2009-06-23
Proteolytically cleavable fusion proteins with high molar specific activity App 20090042787 - Metzner; Hubert ; et al.	2009-02-12
Proteolytically cleavable fusion proteins with high molar specific activity App 20080260755 - Metzner; Hubert ; et al.	2008-10-23
Method for Differentiation of Factor XIII Deficiency States in Relation to Fibrinogen Deficiency States Using Thrombelastographic Techniques App 20080261238 - Wrabetz; Erhardt ; et al.	2008-10-23
Thrombin preparations and process for their production Grant 7,351,561 - Metzner , et al. April 1, 2	2008-04-01
Tissue glue with improved antiadhesive properties Grant 7,276,235 - Metzner , et al. October 2, 2	2007-10-02
Thrombin preparations and process for their production App 20060182735 - Metzner; Hubert ; et al.	2006-08-17
Storage-stable, liquid fibrinogen formulation Grant 7,045,601 - Metzner , et al. May 16, 2	2006-05-16
Fibrinogen purification App 20050197493 - Metzner, Hubert ; et al.	2005-09-08
Storage-stable, liquid fibrinogen formulation App 20050080009 - Metzner, Hubert ; et al.	2005-04-14
Use of a hydrogen peroxide plasma sterilization method for the mild sterilization of temperature-sensitive products Grant 6,790,410 - Metzner , et al. September 14, 2	2004-09-14
Tissue glue with improved antiadhesive properties App 20030133928 - Metzner, Hubert ; et al.	2003-07-17
Use of a hydrogen peroxide plasma sterilization method for the mild sterilization of temperature-sensitive products App 20030003014 - Metzner, Hubert ; et al.	2003-01-02
Stabilized protein preparations for a tissue adhesive Grant 6,447,774 - Metzner , et al. September 10, 2	2002-09-10
Tissue glue with improved antiadhesive properties App 20020001584 - Metzner, Hubert ; et al.	2002-01-03
Thrombin preparations and process for their production App 20010033837 - Metzner, Hubert ; et al.	2001-10-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.